A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity

Previous trials have demonstrated that the combination of noradrenergic reuptake inhibitors with an antimuscarinic can substantially reduce the apnoea‐hypopnoea index (AHI) and improve airway collapsibility in patients with obstructive sleep apnoea (OSA). However, some studies have shown that when a...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomson, Luke D. J., Landry, Shane A., Joosten, Simon A., Mann, Dwayne L., Wong, Ai‐Ming, Cheung, Tim, Adam, Mulki, Beatty, Caroline J., Hamilton, Garun S., Edwards, Bradley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419156/
https://www.ncbi.nlm.nih.gov/pubmed/36029192
http://dx.doi.org/10.14814/phy2.15440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419156/
https://www.ncbi.nlm.nih.gov/pubmed/36029192
http://dx.doi.org/10.14814/phy2.15440

Ejemplares similares